Cargando…
Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma
OBJECTIVE: To explore the clinical utility of circulating tumor DNA (ctDNA) in esophageal adenocarcinoma (EAC) by developing a cost-effective and rapid technique utilising targeted amplicon sequencing. SUMMARY OF BACKGROUND DATA: Emerging evidence suggests that levels of ctDNA in the blood can be us...
Autores principales: | Cabalag, Carlos S., Yates, Michael, Corrales, Mariana Benitez, Yeh, Paul, Wong, Stephen Q., Zhang, Bonnie Z., Fujihara, Kenji M., Chong, Lynn, Hii, Michael W., Dawson, Sarah-Jane, Phillips, Wayne A., Duong, Cuong P., Clemons, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259043/ https://www.ncbi.nlm.nih.gov/pubmed/35737908 http://dx.doi.org/10.1097/SLA.0000000000005177 |
Ejemplares similares
-
ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
por: Cabalag, Carlos S., et al.
Publicado: (2022) -
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
por: Cabalag, Carlos S., et al.
Publicado: (2022) -
Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
por: Milne, Julia V., et al.
Publicado: (2021) -
Inhibiting system x(C)(−) and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers
por: Clemons, Nicholas J., et al.
Publicado: (2017) -
Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)